Bavarian Nordic maintains 2022 guidance

The biotech company reveals it is maintaining its full-year guidance in a statement connected to the release of its quarterly report. (Updated)
Photo: Philip Davali/Ekstra Bladet, Philip Davali
Photo: Philip Davali/Ekstra Bladet, Philip Davali
by christopher due karlsson, translated by catherine brett

On Monday, Bavarian Nordic released its accounts for the first three months of 2022, and took the opportunity to state it is maintaining its full-year guidance.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading